Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 103kWORD 23k
29 May 2015
E-008594-15
Question for written answer E-008594-15
to the Commission
Rule 130
Ángela Vallina (GUE/NGL)

 Subject:  Participation of Israeli firms in the Horizon 2020 programme
 Answer in writing 

The Horizon 2020 programme is a research and innovation programme with around EUR 80 billion available over the period from 2014 to 2020 with a view to driving sustainable growth through investment in science.

On 7 May 2015 a large number of Palestinian organisations signed a letter addressed to the High Representative and to the President of the Commission seeking to stop funds from the Horizon 2020 programme going to Israeli military firms such as Elbit Systems, because of its proven participation in the 2014 military operation against the population of the Gaza Strip, which claimed the lives of around 2 500 people.

In reply to Written Question E-002399/2015, Commissioner Johannes Hahn stated that ‘the EU and Israel have signed an agreement for Israeli participation in the EU’s Horizon 2020 research and innovation programme’. Which Israeli companies are beneficiaries and for how much?

In accordance with its international undertakings, the Treaties of the Union and the EU-Israel Association Agreement, has it been substantiated that the companies in receipt of funds from Horizon 2020 programmes have not had any direct involvement in any military operation that might put at risk the EU’s commitment against dual-use technology?

Original language of question: ES 
Legal notice